Christopher Keenan | VP of IR & Corporate Communications |
Sean McCarthy | Chairman, CEO & President |
Robin Knifsend | VP, Finance |
Jackson Harvey | Nomura Securities |
Alec Stranahan | Bank of America Merrill Lynch |
Waleed Abdel-Naby | SunTrust |
Mohit Bansal | Citigroup |
Boris Peaker | Cowen and Company |
Joseph Catanzaro | Piper Jaffray Companies |
Ashiq Mubarack | Wedbush Securities |
Biren Amin | Jefferies |
Good day, ladies and gentlemen, and welcome to the CytomX Therapeutics First Quarter 2019 Financial Conference Call. [Operator Instructions].
As a reminder, this call may be recorded. I would now like to introduce your host for today's conference, Mr. Christopher Keenan, Vice President of Investor Relations.